Introduction
The Office for Life Sciences has commissioned a flagship initiative which aims to assess the sector’s contribution through manufacturing and research and development (R&D) activities across the United Kingdom. As part of this project, KPMG, with the support of the Association of British HealthTech Industries (ABHI), has released a survey to assess HealthTech activities throughout the UK. The survey will remain open until August 4th, 2023. We strongly encourage all HealthTech companies to participate. Your organisation’s information is crucial for obtaining valuable insights into the HealthTech industry in the UK.
Survey background
Please be aware that references to “you” or “your” within this survey pertain to the UK-based organisation to which this survey was addressed. For global organisations headquartered outside of the UK, the questions pertain specifically to your activities and operations within the UK.
The purpose of this survey is to gather data that is specifically related to the HealthTech sector, which encompasses medical devices, diagnostic technologies, and digital health technologies. If your company operates in both the pharmaceutical and HealthTech industries, we kindly request that you provide your responses with a focus on the HealthTech aspect rather than pharmaceuticals.
We kindly ask that you provide accurate and reliable information to the best of your knowledge.